14 search results

GVDN study says mRNA vaccines aren't brain-safe

Croatian government warned healthcare workers against side effects of the COVID 19 vaccines but hide them from people

A pause on all US vaccinations with the Johnson & Johnson Covid shot will continue for at least another week after members of a government-convened expert panel said Wednesday they needed more time to…

A group of medical experts convened by the US Centers for Disease Control and Prevention (CDC) was holding a meeting on the J&J Covid vaccine on Wednesday, and might recommend new restrictions on its …

A European Medicines Agency (EMA) recommendation Wednesday that a dangerous type of blood clot should be listed as a "very rare side effect" of the AstraZeneca jab stopped just short of saying there i…

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population, and what causes them if they are…

Persistent questions on whether rare but serious blood clots among those getting the AstraZeneca jab against Covid-19 are more frequent than in the general population, and what causes them if they are…

New expert consensus guidelines on the use of immunoglobulin replacement therapy (IgRT) in patients with haematological malignancy and secondary antibody deficiencies (SAD) were recently published in …

A second @nytimes article quotes doctors who say the mRNA technology used in #COVID #vaccines may cause immune thrombocytopenia, a blood disorder that last month led to the death of a Florida doctor a…

Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual meeting. The ProDERM study assesse…

Octapharma is pleased to announce that the first site for the international PRO-SID (Primary Infection Prophylaxis with Panzyga® in Secondary Immunodeficiency in Chronic Lymphocytic Leukaemia) study w…

Topline results from a retrospective study in 93 critically ill COVID-19 patients have become available. The data shows that IVIG treatment reduces inflammation, which is associated with poor clinical…

Octapharma has announced that results from the ProCID study were shared for the first time as a poster presentation during the virtual American Academy of Neurology (AAN) 2020 annual meeting. ProCID w…

SAB Biotherapeutics (SAB), a clinical-stage biopharmaceutical development company advancing a new class of immunotherapies, today announced that it has entered into multiple collaboration and option a…